The inoculation, which was to proceed in addition to Phase 1 tests, was jointly developed by the University of Queensland and the Australian Australian biotech company CSL. Australia Australia hoped the vaccine would be available by mid-2021. In a statement, CSL said no serious adverse effects were reported in 216 …
Read More »Subjects Australian Covid-19 vaccine tests end after test subjects return ‘false positive’ HIV results
